NET Cancer webinar series
November 07, 2016|
By Tore Aasbu|
NET Cancer specialist at Asia Pacific Neuroendocrine Tumor Society (APNETS) conference 2016.
Webinar Series with NET Cancer specialists
Find more from the CNETS Ipsen Webinar Series at https://itr8.wistia.com/projects/4eujigyhr0
Thanks to Carcinoid & Neuroendocrine Tumor Society of Singapore, CNETS SG, for sharing and producing the webinar. Also thanks to Ipsen Pharma for their support creating these videos.
Hallmarks of NETs Development
Presentation by Prof. Kjell Oberg, Uppsala University, Sweden. Dr Oberg is Professor of Endocrine Oncology and has a long list of distinguished appointments.
Staging G3 NEC using Ki67 grade.
Presentation by David Tai Wai-Meng. Dr David Tai is a Consultant Medical Oncologist at National Cancer Centre Singapore. His area of interest is in gastrointestinal cancers and early developmental therapeutics.
Debate Over PRRT Versus ‘Medical Treatment’
Radiological Theranostics in NETs
Presentation by Sugandha Dureja. Dr.Dureja is a dynamic nuclear medicine physician and thyroid specialist. She is amongst the first Indian Specialists with fellowship training in Theranostics, PRRT and Molecular Radiotherapy from Germany and extensive experience in PET-CT.
Immunotherapy for NETs
Presentation by Dr Kjell Oberg of Upsalla University Hospital, Sweden. Dr Oberg became an immunotherapy pioneer in 2013 when he and Upsalla colleagues announced their Oncolytic Virus research and with journalist Alexander Masters launched a crowd-sourced fundraising effort. The team is currently conducting phase I/II clinical trials of their oncolytic virus candidate – AdVince
Future of NETs Therapy
This Novartis Tea Symposium is the second of a two-part presentation, this part on the future of NETs therapy. Presentation by Marianne Pavel. Dr Pavel is a Senior Physician and Leader of the Section for Neuroendocrine Tumors in the Department of Hepatology and Gastroenterology at the Charité-Universitätsmedizin Berlin, Germany. This presentation is sponsored by Novartis Pharmaceuticals.
Find more from the CNETS Ipsen Webinar Series at
Webinars on neuroendocrine cancer, produced by Carcinoid & Neuroendocrine Tumor Society of Singapore and sponsored by Ipsen Pharmaceuticals.